Sun g (@sunrgu) profile picture
Irving, TX
Joined March 2014
Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)Photo by Sun g (@sunrgu)
$HELP price action all over the places
6
497
$ZYME cheap at this price
160
$PHVS has best drug
3
193
$WGS 5 million United Healthcare UMR members are eligible for WES/WGS starting 2027.
Nov. 1, 2026: UMR will allow eligible exome/genome tests ordered by, or in consultation with, a listed specialist from January 1, 2027. For GeneDx, track completed tests, reimbursement and collections. This is an ordering change, not blanket coverage.
1
2
302
$ASND at 1.5B euro annualized revenue and more than 600mi euros
1
192
$KURA trading at cash
3
219
$APP solid ER $CYTK good ER $RYTM buyout offer $ARM good ER
566
$APP back to $500
156
$MU trading like penny stock
214
$RADX single trial is based on for approval. Very good news for the company
3
229
$VRDN great launch
216
Steep seloff in Bios $XBI
2
183
$ZYME HERIZON-GEA-01 updated overall survival (LBA79 at ESMO): Ziihera + tislelizumab + chemo hit ~40% alive at 3 years, median OS 27 months, and Ziihera + chemo showed a statistically significant OS benefit — 24% reduction in risk of death vs trastuzumab + chemo.
2
260